Vol. 23 No. 4 (2025): Blood Transfusion 4-2025 (July-August)
Full Issue
pdf
Review
Original article
-
Partial s antigen expression in GP(B-A-B) hybrid glycophorins and the corresponding in vitro expression study: Partial s antigen expression in GP(B-A-B)
-
The impact of red cell storage age on transfused patients with sickle cell disease: protocol of a pilot randomized clinical trial to evaluate changes in inflammation and clinical transfusion efficacy: Randomized trial of blood storage age in sickle cell disease
-
Patient Blood Management in pediatric and adolescent bone marrow donors: results from an Italian survey: PBM in pediatric bone marrow donors
-
Impact of leukoreduction on the metabolome of ovine packed red blood cells during refrigerated storage: Metabolomics of ovine stored RBC
-
The tandem CD33-CLL1 CAR-T as an approach to treat acute myeloid leukemia: The tandem CLL1/CD33 CAR-T to treat AML
-
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial: Cord blood platelet rich plasma in vulvar lichen sclerosus
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more